Concept Richtlijn Erfelijke darmkanker 2007 versie 7 - Oncoline

In geval van surveillance is de effectiviteit van jaarlijkse endometriumbiopsie hoger dan vanuitsluitend transvaginale echoscopie.De mogelijkheid van preventieve hysterectomie met medenemen van beide adnexa dientbesproken te worden, in het bijzonder in geval van laparotomie bij een bewezen MMRmutatiedraagsteren een voltooid gezin.Literatuur1. Bernstein L. The risk of breast, endometrial and ovarian cancer in users of hormonalpreparations. Basic Clin Pharmacol Toxicol. 2006;98:288-96.2. Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J et al. Recommendations forfollow-up care of individuals with an inherited predisposition to cancer. I. Hereditarynonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997;277:915-9.3. Dove-Edwin I, Boks D, Goff S, Kenter GG, Carpenter R, Vasen HF et al. The outcome ofendometrial cancer surveillance by ultrasound scan in women at risk of hereditarynonpolyposis colorectal carcinoma. Cancer 2002;94:1708-12.4. Dorum A, Heimdal K, Lovslett K, Kristensen G, Hansen LJ, Sandvei R et al. Prospectivelydetected cancer in familial breast/ovarian cancer screening. Acta Obstet Gynecol Scand1999;78:906-11.5. Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B et al. Hereditary OvarianCancer Clinical Study Group. Salpingo-oophorectomy and the risk of ovarian, fallopiantube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA2006;296:185-92.6. Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJet al. Efficacy of screening women at high risk of hereditary ovarian cancer: results of an11-year cohort study. Int J Gynecol Cancer 2006;16 Suppl 1:54-9.7. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA et al. Riskreducingsalpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl JMed 2002;346:1609-15.8. Laframboise S, Nedelcu R, Murphy J, Cole DE, Rosen B. Use of CA-125 and ultrasoundin high-risk women. Int J Gynecol Cancer 2002;12:86-91.9. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH et al.Recommendations for the care of individuals with an inhereted predisposition to Lynchsyndrome: a systematic review. JAMA 2006 296:1507-17.10. Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, MassugerLF et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologicscreening among women at increased risk of hereditary ovarian cancer. J Clin Oncol2005;23:6890-8.11. Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Hollenstein J, MassugerLF et al. The impact of hormone replacement therapy on menopausal symptoms inyounger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol2006;24:3576-82.12. Meeuwissen PA, Seynaeve C, Brekelmans CT, Meijers-Heijboer HJ. Klijn JG, BurgerCW. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomaticwomen at high risk for ovarian cancer. Gynecol Oncol 2005;97:476-82.13. Renkonen-Sinisalo L, Bützow R, Leminen A, Lehtovirta P, Mecklin JP, Järvinen HJ.Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancersyndrome. Int J Cancer 2006;120:821-4.Concept landelijke richtlijn erfelijke darmkanker versie 7 d.d. 7 november 2007.76